Improving vessel healing with fully bioresorbable drug-eluting stents: more than a pipe dream?
暂无分享,去创建一个
R. Virmani | M. Joner | R. Byrne | T. Koppara
[1] P. Serruys,et al. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial , 2015, European heart journal.
[2] Patrick W Serruys,et al. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. , 2015, European heart journal.
[3] Tissue Characterization of In-Stent Neointima Using Optical Coherence Tomography in the Late Phase After Bare-Metal Stent Implantation--An Ex Vivo Validation Study. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[4] R. Virmani,et al. Thrombogenicity and Early Vascular Healing Response in Metallic Biodegradable Polymer-Based and Fully Bioabsorbable Drug-Eluting Stents , 2015, Circulation. Cardiovascular interventions.
[5] M. Togni,et al. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. , 2015, Journal of the American College of Cardiology.
[6] Antonio Colombo,et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] P. Serruys,et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial , 2015, The Lancet.
[8] A. Kastrati,et al. Bioresorbable drug-eluting stents: an immature technology in need of mature application. , 2015, JACC. Cardiovascular interventions.
[9] P. Serruys,et al. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary ste , 2015, JACC. Cardiovascular interventions.
[10] C. Hamm,et al. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. , 2014, Journal of the American College of Cardiology.
[11] P. Serruys,et al. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. , 2014, European heart journal.
[12] M. Joner,et al. Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography , 2014, The International Journal of Cardiovascular Imaging.
[13] T. Münzel,et al. Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[14] V. Kocka,et al. ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases. , 2013, European heart journal.
[15] Michael Joner,et al. Tissue Characterization After Drug-Eluting Stent Implantation Using Optical Coherence Tomography , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[16] P. Serruys,et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial , 2011, European heart journal.
[17] Ruslan Hlushchuk,et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy , 2010, European heart journal.